share_log

Enliven Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Fairmount Funds Management LLC(6.8%),Peter Harwin(6.8%), etc.

Enliven Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Fairmount Funds Management LLC(6.8%),Peter Harwin(6.8%)等

美股SEC公告 ·  11/14 16:23
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息